Pnc Financial Services Group, Inc. Bioventus Inc. Transaction History

Pnc Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.07 - $2.95 $1,249 - $3,445	1,168 Added 97.9%	2,361 $2,000
Q4 2022 Feb 10, 2023	BUY	$1.81 - $8.14 $2,159 - $9,711	1,193 New	1,193 $3,000
Q2 2022 Aug 12, 2022	BUY	$6.82 - $13.82 $1,111 - $2,252	163 Added 7.62%	2,303 $15,000
Q1 2022 May 12, 2022	BUY	$11.65 - $15.28 $23,649 - $31,018	2,030 Added 1845.45%	2,140 $30,000
Q4 2021 Feb 11, 2022	BUY	$12.37 - $16.77 $123 - $167	10 Added 10.0%	110 $1,000
Q3 2021 Nov 05, 2021	BUY	$13.7 - $17.25 $397 - $500	29 Added 40.85%	100 $1,000
Q2 2021 Aug 06, 2021	BUY	$13.75 - $18.8 $976 - $1,334	71 New	71 $1,000

141

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $655M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.